On the Rationality of Using Abnormal Toxicity as an Indicator of Drug Quality Control

Zhao Shengnan, Hou Peng

Chinese Pharmaceutical Affairs ›› 2020, Vol. 34 ›› Issue (7) : 759-765.

Chinese Pharmaceutical Affairs ›› 2020, Vol. 34 ›› Issue (7) : 759-765. DOI: 10.16153/j.1002-7777.2020.07.005
Quality Management

On the Rationality of Using Abnormal Toxicity as an Indicator of Drug Quality Control

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 34(7): 759-765 https://doi.org/10.16153/j.1002-7777.2020.07.005

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/